Get the Stockscreener App
4.80
0.63%
+0.03
After Hours:
4.71
-0.09
-1.87%
MaxCyte Inc Stock (MXCT) Forecast
The MaxCyte Inc (MXCT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.9051, representing a -18.64% decrease from the current price of $4.80. The highest analyst price target is $5.9267, and the lowest is $1.8834.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MXCT Price Target
Average 3.0333
(-36.81% Downside)
Is MaxCyte Inc (MXCT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 69.25 | Neutral |
| STOCH(9,6) | 71.57 | Neutral |
| STOCHRSI(14) | 91.05 | Sell |
| MACD(12,26) | 0.186 | Buy |
| ADX(14) | 35.71 | Buy |
| William %R | -21.66 | Neutral |
| CCI(14) | 83.74 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.454
Buy
|
4.4987
Buy
|
| MA20 |
4.1145
Buy
|
4.301
Buy
|
| MA50 |
4.143
Buy
|
4.2444
Buy
|
| MA100 |
4.4852
Buy
|
4.2917
Buy
|
| MA200 |
4.1224
Buy
|
4.3702
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, MXCT could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on MXCT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 69.25 indicates that MXCT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.57 indicates that MXCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.05 indicates that MXCT is oversold. This suggests that MXCT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.71 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 83.74 indicates that MXCT is still overbought but not to an extreme extent.
Long-term MXCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about MaxCyte Inc financial reports and earnings history, MaxCyte Inc (MXCT) stock could reach $6.1062 by 2030, $53.10 by 2040 and $84.48 by 2050. See the projected annual prices until 2050 of the MaxCyte Inc stock below:
- MaxCyte Inc (MXCT) is expected to reach an average price of $25.39 in 2035, with a high prediction of $27.27 and a low estimate of $26.38. This indicates an $428.95% rise from the last recorded price of $4.80.
- MaxCyte Inc (MXCT) stock is projected to chart a bullish course in 2040, with an average price target of $54.22, representing an $1,030% surge from its current level. The forecast ranges from a conservative $10.91 to a sky-high $53.10.
- Our analysts predict MaxCyte Inc (MXCT) to jump 751.81% by 2045, soaring from $41.05 to an average price of $40.89, potentially reaching $41.26. While $41.05 is the low estimate, the potential upside is significant.
- MaxCyte Inc (MXCT) stock is expected to climb by 2050, reaching an average of $83.45, a $1,638% jump from its current level. However, a wide range of estimates exists, with high and low targets of $84.48 and $84.45, respectively, highlighting the market's uncertainty.
MaxCyte Inc Stock (MXCT) Year by Year Forecast
MaxCyte Inc Stock (MXCT) Price Forecast for 2024
Our forecast for MXCT stock price in 2024 now indicates an average price target of $3.0333 with a high forecast of $5.9267 and a low forecast of $0.1398. The average prediction reflects an decrease of -36.81% from the last recorded price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $2.6934 | $1.8834 | $5.9267 | -43.89% |
| July, 2024 | $0.2598 | $0.5899 | $2.7468 | -94.59% |
| August, 2024 | $2.0436 | $0.1398 | $2.2436 | -57.43% |
| September, 2024 | $0.073 | $1.073 | $1.9969 | -98.48% |
| October, 2024 | $2.4963 | $0.563 | $1.4763 | -47.99% |
| November, 2024 | $4.2429 | $3.703 | $3.6263 | -11.61% |
| December, 2024 | $2.8795 | $3.4662 | $3.1296 | -40.01% |
MaxCyte Inc Stock (MXCT) Price Forecast for 2025
MaxCyte Inc Stock (MXCT) is expected to reach an average price of $2.8574 in 2025, with a high prediction of $4.8593 and a low estimate of $0.8556. This indicates an -40.47% fall from the last recorded price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.5828 | $3.0928 | $3.7428 | -46.19% |
| February, 2025 | $3.9094 | $2.7694 | $3.6794 | -18.55% |
| March, 2025 | $4.196 | $3.976 | $4.166 | -12.58% |
| April, 2025 | $5.0493 | $4.4993 | $4.8593 | +5.19% |
| May, 2025 | $3.7559 | $4.0892 | $3.8792 | -21.75% |
| June, 2025 | $2.8725 | $3.1225 | $3.4625 | -40.16% |
| July, 2025 | $3.1257 | $2.7558 | $2.7157 | -34.88% |
| August, 2025 | $1.4724 | $2.4674 | $1.5757 | -69.33% |
| September, 2025 | $0.749 | $1.7834 | $1.3123 | -84.40% |
| October, 2025 | $1.3722 | $0.8556 | $1.1415 | -71.41% |
| November, 2025 | $1.9388 | $1.5055 | $1.5138 | -59.61% |
| December, 2025 | $1.6821 | $1.9721 | $1.8555 | -64.96% |
MaxCyte Inc Stock (MXCT) Price Forecast for 2026
The predicted value for MaxCyte Inc (MXCT) in 2026 is set at an average of $1.1566. Estimates vary from a peak of $2.1085 to a trough of $0.2047, indicating an -75.90% surge from the present price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.5987 | $1.2504 | $1.0987 | -66.69% |
| February, 2026 | $1.8153 | $1.9554 | $1.9087 | -62.18% |
| March, 2026 | $1.4219 | $2.212 | $1.9486 | -70.38% |
| April, 2026 | $1.3452 | $1.2819 | $1.2187 | -71.98% |
| May, 2026 | $1.8118 | $1.9468 | $2.1085 | -62.25% |
| June, 2026 | $0.9984 | $1.1918 | $1.4584 | -79.20% |
| July, 2026 | $0.9317 | $0.6377 | $0.9851 | -80.59% |
| August, 2026 | $1.4783 | $0.9683 | $1.3033 | -69.20% |
| September, 2026 | $1.5115 | $1.3684 | $1.3199 | -68.51% |
| October, 2026 | $1.8081 | $1.7782 | $1.6048 | -62.33% |
| November, 2026 | $1.0848 | $1.5848 | $1.5481 | -77.40% |
| December, 2026 | $0.742 | $0.2047 | $0.8014 | -84.54% |
MaxCyte Inc Stock (MXCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for MaxCyte Inc (MXCT) is $6.5773, with a high forecast of $12.80 and a low forecast of $0.3587. This indicates an +37.03% increase from the last price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6754 | $0.3587 | $1.1653 | -85.93% |
| February, 2027 | $1.2188 | $0.3637 | $1.6271 | -74.61% |
| March, 2027 | $1.0455 | $0.8605 | $1.5355 | -78.22% |
| April, 2027 | $0.9789 | $0.5189 | $1.3622 | -79.61% |
| May, 2027 | $0.8823 | $0.7922 | $1.3322 | -81.62% |
| June, 2027 | $7.82 | $0.574 | $6.70 | +62.92% |
| July, 2027 | $5.5732 | $7.6732 | $7.0066 | +16.11% |
| August, 2027 | $10.15 | $7.3865 | $8.4264 | +111.38% |
| September, 2027 | $10.59 | $11.71 | $10.88 | +120.69% |
| October, 2027 | $11.66 | $9.6729 | $9.8263 | +142.84% |
| November, 2027 | $10.95 | $11.61 | $11.18 | +128.11% |
| December, 2027 | $13.84 | $10.94 | $12.80 | +188.25% |
MaxCyte Inc Stock (MXCT) Price Forecast for 2028
In 2028, MaxCyte Inc (MXCT) is projected to reach an average price of $11.15, with a high projection of $13.74 and a low estimate of $8.5612. This indicates an +132.29% rise from the last price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.45 | $14.30 | $13.73 | +180.19% |
| February, 2028 | $13.68 | $13.41 | $13.01 | +185.05% |
| March, 2028 | $12.23 | $12.29 | $13.48 | +154.77% |
| April, 2028 | $13.07 | $13.13 | $13.04 | +172.34% |
| May, 2028 | $13.47 | $13.54 | $13.35 | +180.60% |
| June, 2028 | $12.62 | $13.82 | $13.74 | +162.95% |
| July, 2028 | $12.53 | $12.61 | $12.60 | +160.94% |
| August, 2028 | $11.07 | $11.10 | $11.58 | +130.66% |
| September, 2028 | $9.8848 | $11.14 | $10.90 | +105.93% |
| October, 2028 | $9.178 | $9.7024 | $9.6014 | +91.21% |
| November, 2028 | $8.3545 | $8.5612 | $9.1246 | +74.05% |
| December, 2028 | $8.8878 | $8.9711 | $8.6338 | +85.16% |
MaxCyte Inc Stock (MXCT) Price Forecast for 2029
The 2029 price forecast for MaxCyte Inc Stock (MXCT) is $7.5919 on average, with a high prediction of $9.081 and a low estimate of $6.1027. This represents an +58.16% increase from the previous price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.8843 | $8.8911 | $9.081 | +85.09% |
| February, 2029 | $8.1475 | $8.6775 | $8.7176 | +69.74% |
| March, 2029 | $8.6407 | $8.1558 | $8.2707 | +80.01% |
| April, 2029 | $8.6739 | $8.7439 | $8.5473 | +80.71% |
| May, 2029 | $7.1805 | $7.6955 | $8.4272 | +49.59% |
| June, 2029 | $8.2787 | $7.4938 | $7.2571 | +72.47% |
| July, 2029 | $7.3069 | $7.6969 | $8.107 | +52.23% |
| August, 2029 | $6.5134 | $6.8661 | $6.8802 | +35.70% |
| September, 2029 | $6.2466 | $6.1027 | $6.1366 | +30.14% |
| October, 2029 | $6.5232 | $6.3349 | $6.5015 | +35.90% |
| November, 2029 | $6.6464 | $6.4067 | $6.3464 | +38.47% |
| December, 2029 | $6.2096 | $6.4696 | $6.4297 | +29.37% |
MaxCyte Inc Stock (MXCT) Price Forecast for 2030
MaxCyte Inc Stock (MXCT) is expected to reach an average price of $12.04 in 2030, with a high forecast of $21.89 and a low forecast of $2.1986. This signifies an +150.92% surge from the last price of $4.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6461 | $5.5061 | $6.1062 | -3.21% |
| February, 2030 | $3.5193 | $3.8093 | $3.8844 | -26.68% |
| March, 2030 | $3.3426 | $3.6076 | $3.3417 | -30.36% |
| April, 2030 | $2.4258 | $2.6408 | $2.4092 | -49.46% |
| May, 2030 | $2.3823 | $2.4241 | $2.409 | -50.37% |
| June, 2030 | $2.1355 | $2.3156 | $2.2522 | -55.51% |
| July, 2030 | $2.312 | $2.2354 | $2.1237 | -51.83% |
| August, 2030 | $20.30 | $2.1986 | $18.47 | +322.92% |
| September, 2030 | $18.65 | $18.72 | $18.50 | +288.54% |
| October, 2030 | $22.80 | $19.51 | $21.89 | +374.99% |
| November, 2030 | $21.19 | $21.98 | $21.84 | +341.45% |
| December, 2030 | $21.94 | $20.42 | $21.82 | +357.07% |
2.41%
0.21%
Cap:
|
Volume (24h):